We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 134

Decree on advertising medical devices in France

  • Hodgson Russ LLP
  • -
  • France
  • -
  • August 27 2012

A new French law wants to strengthen the safety of drugs and medical products

Final rules: essential health benefits, cost-sharing, and actuarial value

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • May 31 2013

Beginning in 2014, non-grandfathered individual health insurance policies and policies issued to small employers must provide "essential health

New French Sunshine Act guidance

  • Hodgson Russ LLP
  • -
  • France, USA
  • -
  • July 11 2013

On June 12, 2013, the French Ministry of Health published Circulaire No. DGSPF22013224 relative to Article 2 of the Law No. 2011-2012 of December

The Trade Adjustment Assistance Extension Act extends Health Coverage Tax Credit

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • December 21 2011

On October 11, 2011, the Trade Adjustment Assistance Extension Act was signed into law

The application of the medical device excise tax to foreign manufacturers selling to end-users in the United States

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • May 6 2013

As of January 1, 2013, the first sale of a taxable medical device in the United States by a manufacturer, producer, or importer has been subject to a

MEWA held to be not fully insured under ERISA

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • April 15 2011

When unrelated employers join together in an association or other group to purchase or arrange for health insurance, the association is defined as a "multiple employer welfare arrangement" or "MEWA" under the law

Clinical trial financial disclosure: French legislation

  • Hodgson Russ LLP
  • -
  • France
  • -
  • September 6 2011

The European Parliament and Council’s Directive 200120EC dated April 4, 2001, which has been modified several times, is related to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use

Establishment registration: FDA's new importer disclosure policy burdens foreign establishments

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • October 24 2012

A foreign establishment cannot register with the FDA for the fiscal year 2013 without disclosing the names, addresses, and phone numbers of “all known importers” of its device in the United States

Guidance on HRAs and other employer payment plans

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • November 26 2013

Under ACA for 2014. The Treasury and Department of Labor recently published guidance on the application of the Affordable Care Act Market Reforms on

American Sleep Medicine to pay more than $15.3m to resolve allegations of Medicare fraud

  • Hodgson Russ LLP
  • -
  • USA
  • -
  • February 7 2013

The federal government recently settled a $15 million False Claims Act (FCA) case against American Sleep Medicine LLC, according to a recent Justice